Jefferies Group LLC Atea Pharmaceuticals, Inc. Transaction History

Jefferies Group LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$5.33 - $8.18 $65,633 - $100,728	-12,314 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$5.5 - $9.19 $39,743 - $66,406	-7,226 Reduced 36.98%	12,314 $56,000
Q4 2021 Sep 21, 2023	BUY	$7.67 - $44.59 $57,525 - $334,425	7,500 New	7,500 $67,000
Q4 2021 Feb 14, 2022	BUY	$7.67 - $44.59 $149,871 - $871,288	19,540 New	19,540 $120,000

112

52.4M

900

126K

Ticker AVIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,258,600
Market Cap $275M
Description
Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.